| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| methotrimeprazine | alpha-1a adrenergic receptor | small molecule | NA | drugbank , DGIDB | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
0.17 | approved,investigational | antagonist |
| methotrimeprazine | alpha-1b adrenergic receptor | small molecule | NA | drugbank , DGIDB | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
0.23 | approved,investigational | antagonist |
| methotrimeprazine | alpha-1d adrenergic receptor | small molecule | NA | drugbank , DGIDB | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
0.39 | approved,investigational | antagonist |
| methotrimeprazine | alpha-2a adrenergic receptor | small molecule | NA | drugbank | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | antagonist |
| methotrimeprazine | alpha-2b adrenergic receptor | small molecule | NA | drugbank | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | antagonist |
| methotrimeprazine | alpha-2c adrenergic receptor | small molecule | NA | drugbank | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | antagonist |
| methotrimeprazine | muscarinic acetylcholine receptor m1 | small molecule | NA | drugbank , DGIDB | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
0.16 | approved,investigational | antagonist |
| methotrimeprazine | muscarinic acetylcholine receptor m2 | small molecule | NA | drugbank , DGIDB | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
0.22 | approved,investigational | antagonist |
| methotrimeprazine | muscarinic acetylcholine receptor m3 | small molecule | NA | drugbank , DGIDB | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
0.18 | approved,investigational | antagonist |
| methotrimeprazine | muscarinic acetylcholine receptor m4 | small molecule | NA | drugbank , DGIDB | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
0.31 | approved,investigational | antagonist |
| methotrimeprazine | muscarinic acetylcholine receptor m5 | small molecule | NA | drugbank , DGIDB | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
0.28 | approved,investigational | antagonist |
| methotrimeprazine | dopamine d1 receptor | small molecule | NA | drugbank | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | antagonist |
| methotrimeprazine | dopamine d2 receptor | small molecule | NA | drugbank | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | antagonist |
| methotrimeprazine | dopamine d3 receptor | small molecule | NA | drugbank , DGIDB | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
0.21 | approved,investigational | antagonist |
| methotrimeprazine | dopamine d4 receptor | small molecule | NA | drugbank | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | antagonist |
| methotrimeprazine | dopamine d5 receptor | small molecule | NA | drugbank | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | antagonist |
| methotrimeprazine | histamine h1 receptor | small molecule | NA | drugbank , DGIDB | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
0.09 | approved,investigational | antagonist |
| methotrimeprazine | 5-hydroxytryptamine receptor 2a | small molecule | NA | drugbank | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | antagonist |
| methotrimeprazine | 5-hydroxytryptamine receptor 2c | small molecule | NA | drugbank | Manic Disorder[MeSHID:D001714] Schizophrenia[MeSHID:D012559] Psychotic Disorders[MeSHID:D011618] |
NA | approved,investigational | antagonist |
| click here to return to the previous page | ||||||||